- Metformin is the most commonly used therapy for type 2 diabetes since it helps lower blood glucose.
- Studies have shown metformin may also reduce the risk of some cancers in type 2 diabetes.
- New research has shown that metformin alters levels of microRNAs that target genes to slow the growth and multiplication of colorectal cancer cells.
- The researchers suggest their findings could lead to new RNA therapeutics for cancer prevention and treatment.
Metformin is a common treatment for type 2…
Read the full article here